CareRx Corporation (CHHHF)
USD 1.28
(0.0%)
USD 1.28
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 77.49 Million CAD | -24.25% |
| 2022 | 102.3 Million CAD | 45.17% |
| 2021 | 70.46 Million CAD | 45.4% |
| 2020 | 48.46 Million CAD | 15.73% |
| 2019 | 41.87 Million CAD | 0.52% |
| 2018 | 41.65 Million CAD | -23.72% |
| 2017 | 54.61 Million CAD | -8.15% |
| 2016 | 59.45 Million CAD | -7.23% |
| 2015 | 64.09 Million CAD | -47.77% |
| 2014 | 122.72 Million CAD | -45.53% |
| 2013 | 225.29 Million CAD | 5.77% |
| 2012 | 213.01 Million CAD | 308.32% |
| 2011 | 52.16 Million CAD | 469.7% |
| 2010 | 9.15 Million CAD | 22.67% |
| 2009 | 7.46 Million CAD | 80.52% |
| 2008 | 4.13 Million CAD | 17.76% |
| 2007 | 3.51 Million CAD | 135.99% |
| 2006 | 1.48 Million CAD | 10.08% |
| 2005 | 1.35 Million CAD | -73.18% |
| 2004 | 5.04 Million CAD | 26.67% |
| 2003 | 3.97 Million CAD | 6552.64% |
| 2002 | 59.81 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 20.12 Million CAD | 3.45% |
| 2024 Q1 | 19.45 Million CAD | 4.46% |
| 2023 Q3 | 25.09 Million CAD | 2.08% |
| 2023 Q1 | 24.23 Million CAD | -5.14% |
| 2023 Q4 | 18.62 Million CAD | -25.79% |
| 2023 FY | 77.49 Million CAD | -24.25% |
| 2023 Q2 | 24.58 Million CAD | 1.43% |
| 2022 Q2 | 25.77 Million CAD | 1.78% |
| 2022 Q3 | 25.65 Million CAD | -0.47% |
| 2022 Q4 | 25.54 Million CAD | -0.43% |
| 2022 FY | 102.3 Million CAD | 45.17% |
| 2022 Q1 | 25.32 Million CAD | -32.59% |
| 2021 Q4 | 37.56 Million CAD | 102.19% |
| 2021 Q3 | 18.58 Million CAD | 29.88% |
| 2021 Q2 | 14.3 Million CAD | 9.2% |
| 2021 Q1 | 13.1 Million CAD | -14.68% |
| 2021 FY | 70.46 Million CAD | 45.4% |
| 2020 Q2 | 11.29 Million CAD | 18.39% |
| 2020 Q1 | 9.54 Million CAD | -13.73% |
| 2020 FY | 48.46 Million CAD | 15.73% |
| 2020 Q3 | 12.27 Million CAD | 8.64% |
| 2020 Q4 | 15.35 Million CAD | 25.12% |
| 2019 Q2 | 10.3 Million CAD | -0.02% |
| 2019 Q1 | 10.3 Million CAD | 1756.91% |
| 2019 FY | 41.87 Million CAD | 0.52% |
| 2019 Q4 | 11.06 Million CAD | 7.05% |
| 2019 Q3 | 10.33 Million CAD | 0.27% |
| 2018 Q2 | 14.17 Million CAD | -1.44% |
| 2018 Q4 | -622 Thousand CAD | -104.62% |
| 2018 FY | 41.65 Million CAD | -23.72% |
| 2018 Q1 | 14.38 Million CAD | 5.1% |
| 2018 Q3 | 13.47 Million CAD | -4.96% |
| 2017 Q1 | 13.51 Million CAD | -1.86% |
| 2017 FY | 54.61 Million CAD | -8.15% |
| 2017 Q4 | 13.68 Million CAD | 2.72% |
| 2017 Q3 | 13.32 Million CAD | 2.45% |
| 2017 Q2 | 13 Million CAD | -3.75% |
| 2016 Q1 | 15.22 Million CAD | 147.36% |
| 2016 Q2 | 15.41 Million CAD | 1.25% |
| 2016 FY | 59.45 Million CAD | -7.23% |
| 2016 Q3 | 15.04 Million CAD | -2.41% |
| 2016 Q4 | 13.76 Million CAD | -8.49% |
| 2015 FY | 64.09 Million CAD | -47.77% |
| 2015 Q1 | 31.99 Million CAD | 2.88% |
| 2015 Q4 | -32.14 Million CAD | -200.85% |
| 2015 Q3 | 31.87 Million CAD | -1.54% |
| 2015 Q2 | 32.37 Million CAD | 1.2% |
| 2014 Q3 | 30.18 Million CAD | -3.35% |
| 2014 FY | 122.72 Million CAD | -45.53% |
| 2014 Q1 | 45.63 Million CAD | -16.56% |
| 2014 Q4 | 31.09 Million CAD | 3.01% |
| 2014 Q2 | 31.23 Million CAD | -31.57% |
| 2013 FY | 225.29 Million CAD | 5.77% |
| 2013 Q3 | 54.18 Million CAD | -9.84% |
| 2013 Q2 | 60.09 Million CAD | 6.72% |
| 2013 Q1 | 56.31 Million CAD | -14.29% |
| 2013 Q4 | 54.69 Million CAD | 0.95% |
| 2012 Q4 | 65.7 Million CAD | 30.48% |
| 2012 Q2 | 10.99 Million CAD | -56.11% |
| 2012 Q1 | 25.05 Million CAD | -8.6% |
| 2012 Q3 | 50.35 Million CAD | 358.01% |
| 2012 FY | 213.01 Million CAD | 308.32% |
| 2011 Q4 | 27.4 Million CAD | 108.48% |
| 2011 Q2 | 3.07 Million CAD | 27.68% |
| 2011 Q3 | 13.14 Million CAD | 327.93% |
| 2011 Q1 | 2.4 Million CAD | -11.96% |
| 2011 FY | 52.16 Million CAD | 469.7% |
| 2010 Q1 | 1.92 Million CAD | -43.68% |
| 2010 FY | 9.15 Million CAD | 22.67% |
| 2010 Q2 | 2.32 Million CAD | 20.63% |
| 2010 Q4 | 2.73 Million CAD | 25.66% |
| 2010 Q3 | 2.17 Million CAD | -6.29% |
| 2009 Q3 | 1.6 Million CAD | 5.18% |
| 2009 Q1 | 1.46 Million CAD | -23.73% |
| 2009 Q2 | 1.52 Million CAD | 4.1% |
| 2009 FY | 7.46 Million CAD | 80.52% |
| 2009 Q4 | 3.41 Million CAD | 113.1% |
| 2008 Q3 | 695.61 Thousand CAD | -10.58% |
| 2008 Q4 | 1.91 Million CAD | 175.93% |
| 2008 FY | 4.13 Million CAD | 17.76% |
| 2008 Q1 | 754.63 Thousand CAD | -68.27% |
| 2008 Q2 | 777.91 Thousand CAD | 3.09% |
| 2007 Q3 | 365.56 Thousand CAD | 1.91% |
| 2007 Q2 | 358.7 Thousand CAD | 8.38% |
| 2007 Q1 | 330.95 Thousand CAD | -49.35% |
| 2007 FY | 3.51 Million CAD | 135.99% |
| 2007 Q4 | 2.37 Million CAD | 550.5% |
| 2006 Q1 | 251.14 Thousand CAD | 210.13% |
| 2006 FY | 1.48 Million CAD | 10.08% |
| 2006 Q2 | 287.7 Thousand CAD | 14.56% |
| 2006 Q4 | 653.36 Thousand CAD | 120.83% |
| 2006 Q3 | 295.86 Thousand CAD | 2.84% |
| 2005 Q3 | 612.55 Thousand CAD | -67.91% |
| 2005 Q1 | 1.79 Million CAD | 5.8% |
| 2005 FY | 1.35 Million CAD | -73.18% |
| 2005 Q2 | 1.9 Million CAD | 6.07% |
| 2005 Q4 | -228.03 Thousand CAD | -137.23% |
| 2004 Q2 | 961.01 Thousand CAD | 1.04% |
| 2004 FY | 5.04 Million CAD | 26.67% |
| 2004 Q4 | 1.7 Million CAD | 19.11% |
| 2004 Q3 | 1.42 Million CAD | 48.58% |
| 2004 Q1 | 951.16 Thousand CAD | 461.28% |
| 2003 Q2 | 1.41 Million CAD | 3056.38% |
| 2003 Q1 | 44.98 Thousand CAD | 218.08% |
| 2003 FY | 3.97 Million CAD | 6552.64% |
| 2003 Q4 | -263.27 Thousand CAD | -117.64% |
| 2003 Q3 | 1.49 Million CAD | 5.11% |
| 2002 Q4 | 14.14 Thousand CAD | -59.01% |
| 2002 Q3 | 34.5 Thousand CAD | 208.89% |
| 2002 FY | 59.81 Thousand CAD | 0.0% |
| 2002 Q2 | 11.17 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | -20.958% |
| Arem Pacific Corporation | 367.08 Thousand USD | -21011.474% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -9193.145% |
| BioCorRx Inc. | 3.84 Million USD | -1917.615% |
| Bionik Laboratories Corp. | 5.81 Million USD | -1232.711% |
| Banyan Corp. | 6.59 Million USD | -1074.614% |
| Clearday, Inc. | 5 Million USD | -1449.077% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -2265.669% |
| Quantum Medical Transport, Inc. | 874.76 USD | -8859015.643% |
| Empower Clinics Inc. | 6.92 Million USD | -1019.506% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -3075.525% |
| Selectis Health, Inc. | 14.36 Million USD | -439.382% |
| Ethema Health Corporation | 5.27 Million USD | -1369.926% |
| HealthLynked Corp. | 9.73 Million USD | -696.334% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | -721.021% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -11438.169% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | -2.837% |
| MedSmart Group Inc. | 65.47 Thousand USD | -118266.911% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -9889.752% |
| Nova Leap Health Corp. | 9.3 Million USD | -732.554% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -13903.892% |
| PAO Group, Inc. | 45.42 Thousand USD | -170520.872% |
| Primemd Inc. | 6.25 Million USD | -1138.375% |
| Raffles Medical Group Ltd | 151.69 Million USD | 48.912% |
| Ryman Healthcare Limited | 9.61 Million USD | -706.155% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -1830658.327% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -5512.508% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -12465.751% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -10030.196% |
| Veltex Corporation | 1.77 Million USD | -4260.786% |
| World Financial Holding Group | 28.42 Thousand USD | -272523.654% |
| Xcelerate Inc. | 2.9 Million USD | -2566.04% |